Status:
COMPLETED
The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer
Lead Sponsor:
University of Copenhagen
Conditions:
Cancer Cachexia
Side Effects
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The aim of this study is to determine the effects of n-3 PUFAs on weight, physical funktion and quality of life in patients with colorectal cancer.
Detailed Description
Primary outcomes: * Weight * Physical function * Hand-grip strength Secondary outcomes: * Quality of life * Mid-upperarm circumference * Incorporation of n-3 PUFAs into cell membranes
Eligibility Criteria
Inclusion
- ≥18 years
- Patients with diagnosed colorectal cancer with metastases treated with chemotherapy on Rigshospitalet, Copenhagen
Exclusion
- \< 18 years
- Patients in palliative care
- patients with haemophilia
- Patiens in treatment of anti-coagulation
- Patients with genetic hyperkolesterolemia
- Pre-dialytic patients (GFR\<15ml/min/1,73m2 eller kreatinin ≥500 mmol/L)
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04699760
Start Date
April 1 2015
End Date
September 1 2015
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departmen of Oncology, Rigshospital
Copenhagen, Denmark, 2100 OE